Nearly One Third of Lupus Patients in One Study Had Low Responses to COVID-19 Vaccines – Newswise

Newswise — ATLANTA — New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that nearly 30% of patients with lupus in a multi-ethnic and multi-racial study had a low response to the new COVID-19…

Click here to view the original article.